Development Level

Tchem 12 | 1,598
Tbio 8 | 11,445
Tdark 4 | 6,588

IMPC Phenotype

cataract 2 | 92
abnormal lens morphology 1 | 81
decreased grip strength 1 | 116
decreased leukocyte cell numbe... 1 | 73
increased body weight 1 | 25
increased circulating sodium l... 1 | 71
increased grip strength 1 | 41
male infertility 1 | 123
preweaning lethality, incomple... 1 | 499

Disease

psoriasis 12 | 6,694
Carcinoma 10 | 11,493
osteosarcoma 9 | 7,950
ovarian cancer 9 | 8,520
lung cancer 8 | 4,740
medulloblastoma, large-cell 7 | 6,241
Bipolar Disorder 6 | 666
Schizophrenia 6 | 1,160
interstitial cystitis 6 | 2,312
lung adenocarcinoma 6 | 2,716
pancreatic ductal adenocarcinoma liver metastasis 6 | 1,962
Toxic encephalopathy 5 | 141
diabetes mellitus 5 | 1,728
malignant mesothelioma 5 | 3,232
non-small cell lung cancer 5 | 2,890
pancreatic cancer 5 | 2,398
Atherosclerosis 4 | 291
Coronary artery disease 4 | 268
active Crohn's disease 4 | 922
atypical teratoid / rhabdoid tumor 4 | 5,112
ependymoma 4 | 4,679
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
lung carcinoma 4 | 2,843
pituitary cancer 4 | 1,972
ulcerative colitis 4 | 1,819
Arthritis 3 | 290
Breast cancer 3 | 3,578
Cancer 3 | 2,499
Epilepsy 3 | 792
Gas gangrene 3 | 17
Ileocolitis 3 | 5
Kidney cancer 3 | 2,613
Rheumatoid arthritis 3 | 1,191
Zellweger syndrome 3 | 37
adrenocortical carcinoma 3 | 1,428
adult high grade glioma 3 | 3,801
astrocytoma 3 | 1,146
breast carcinoma 3 | 1,638
glioblastoma 3 | 5,792
group 4 medulloblastoma 3 | 1,855
invasive ductal carcinoma 3 | 2,951
pancreatic carcinoma 3 | 562
primitive neuroectodermal tumor 3 | 3,035
Abnormal visual evoked potential 2 | 26
Abnormality of metabolism/homeostasis 2 | 134
Acute pancreatitis 2 | 10
Autosomal recessive predisposition 2 | 1,442
Babinski Reflex 2 | 100
Cerebrovascular disease 2 | 238
Cognitive delay 2 | 608
Colorectal Neoplasms 2 | 243
Deglutition Disorders 2 | 132
Depressive disorder 2 | 409
Developmental regression 2 | 95
Dystonia 2 | 164
Dystonic disease 2 | 106
Frontal bossing 2 | 157
Global developmental delay 2 | 608
Hyperreflexia 2 | 209
Infantile onset 2 | 238
Liver Cirrhosis, Experimental 2 | 769
Loss of developmental milestones 2 | 95
MAJOR AFFECTIVE DISORDER 2 2 | 22
Membranous glomerulonephritis 2 | 13
Mental and motor retardation 2 | 608
Mental deterioration in childhood 2 | 95
Multiple myeloma 2 | 1,332
Muscle hypotonia 2 | 571
Neurodegeneration with brain iron accumulation 2 | 20
Neurodevelopmental regression 2 | 95
Nystagmus 2 | 317
Obesity 2 | 678
Optic Atrophy 2 | 242
Psychomotor regression 2 | 95
Psychomotor regression beginning in infancy 2 | 95
Psychomotor regression in infants 2 | 95
Psychomotor regression, progressive 2 | 95
Seizures 2 | 596
Strabismus 2 | 270
active ulcerative colitis 2 | 764
alpha-methylacyl-CoA racemase deficiency 2 | 9
astrocytic glioma 2 | 2,597
colon cancer 2 | 1,478
cystic fibrosis 2 | 1,696
ductal carcinoma in situ 2 | 1,745
esophageal adenocarcinoma 2 | 737
group 3 medulloblastoma 2 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
oligodendroglioma 2 | 2,850
subependymal giant cell astrocytoma 2 | 2,287
Cachexia 1 | 50
Carcinoma of colon 1 | 32
Childhood onset 1 | 38
Diabetes Mellitus, Experimental 1 | 108
Hyperactive behavior 1 | 91
Metabolic syndrome X 1 | 52
Neuro-degenerative disease 1 | 43
Nevus 1 | 19
Scotoma 1 | 22

Tissue

Digestive Tract 24 | 17,369
Blood and immune system 23 | 16,909
Skin and soft tissues 23 | 17,230
Endocrine System 22 | 18,159
Female tissues 22 | 17,400
Urinary Tract 22 | 16,678
Male tissues 21 | 17,142
Respiratory system 21 | 16,393
Liver and Pancreas 20 | 16,750
Nervous System 19 | 16,725
Cardiovascular System 17 | 15,192

Target Family

Enzyme 23 | 4,145
Non-IDG 1 | 12,091

KEGG Pathway

alpha-Linolenic acid metabolis... 24 | 24
Metabolic pathways 1,263 | 1,263
Pathways in cancer 530 | 530
Olfactory transduction 414 | 414
Human papillomavirus infection 388 | 388
PI3K-Akt signaling pathway 349 | 349
HTLV-I infection 336 | 336
Endocytosis 310 | 310
MAPK signaling pathway 295 | 295
Epstein-Barr virus infection 280 | 280
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 267 | 267
Herpes simplex infection 262 | 262
Kaposi's sarcoma-associated he... 252 | 252
Viral carcinogenesis 251 | 251
Thermogenesis 232 | 232
Ras signaling pathway 230 | 230
Phagosome 229 | 229
Cellular senescence 228 | 228
Cell adhesion molecules (CAMs) 225 | 225
Rap1 signaling pathway 209 | 209
Regulation of actin cytoskelet... 207 | 207
cAMP signaling pathway 201 | 201
Focal adhesion 198 | 198
Proteoglycans in cancer 198 | 198
Natural killer cell mediated c... 197 | 197
Huntington's disease 194 | 194
Tuberculosis 189 | 189
Calcium signaling pathway 183 | 183
Chemokine signaling pathway 183 | 183
Influenza A 182 | 182
Axon guidance 174 | 174
Purine metabolism 172 | 172
Alzheimer's disease 171 | 171
Transcriptional misregulation ... 171 | 171
Tight junction 169 | 169
Hepatocellular carcinoma 168 | 168
NOD-like receptor signaling pa... 166 | 166
Protein processing in endoplas... 164 | 164
RNA transport 163 | 163
cGMP-PKG signaling pathway 162 | 162
Jak-STAT signaling pathway 161 | 161
Cushing's syndrome 158 | 158
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
Necroptosis 154 | 154
Oxytocin signaling pathway 154 | 154
MicroRNAs in cancer 150 | 150
mTOR signaling pathway 150 | 150
Non-alcoholic fatty liver dise... 149 | 149
Gastric cancer 148 | 148
Retrograde endocannabinoid sig... 148 | 148
Adrenergic signaling in cardio... 147 | 147
Alcoholism 147 | 147
Breast cancer 147 | 147
Phospholipase D signaling path... 147 | 147
Wnt signaling pathway 145 | 145
Hepatitis B 143 | 143
Parkinson's disease 142 | 142
Estrogen signaling pathway 139 | 139
Apoptosis 138 | 138
Fluid shear stress and atheros... 138 | 138
Signaling pathways regulating ... 138 | 138
Insulin signaling pathway 137 | 137
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Apelin signaling pathway 136 | 136
Dopaminergic synapse 135 | 135
Ribosome 134 | 134
Measles 133 | 133
Oxidative phosphorylation 133 | 133
Relaxin signaling pathway 133 | 133
Spliceosome 132 | 132
Autoimmune thyroid disease 130 | 130
FoxO signaling pathway 130 | 130
Hepatitis C 130 | 130
Autophagy - animal 128 | 128
Osteoclast differentiation 127 | 127
Cell cycle 125 | 125
Platelet activation 125 | 125
Toxoplasmosis 125 | 125
Lysosome 123 | 123
Vascular smooth muscle contrac... 123 | 123
Type I diabetes mellitus 122 | 122
Oocyte meiosis 121 | 121
AMPK signaling pathway 120 | 120
Graft-versus-host disease 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Sphingolipid signaling pathway 118 | 118
Allograft rejection 116 | 116
Carbon metabolism 116 | 116
Glutamatergic synapse 116 | 116
Thyroid hormone signaling path... 116 | 116
Serotonergic synapse 114 | 114
Leukocyte transendothelial mig... 112 | 112
Cholinergic synapse 111 | 111
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
TNF signaling pathway 108 | 108
Insulin resistance 107 | 107

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fatty acid desaturase 2 FADS2 Tbio Enzyme -2.55411 349.6 135
Cytosolic phospholipase A2 gamma PLA2G4C Tchem Enzyme -1.27690 20.9 63
Group IIE secretory phospholipase A2 PLA2G2E Tchem Enzyme -0.44734 2.04 30
Cytosolic phospholipase A2 delta PLA2G4D Tbio Enzyme -0.54284 3.41 45
Phospholipase A2, membrane associated PLA2G2A Tchem Enzyme -2.83666 743.3 137
Group IIF secretory phospholipase A2 PLA2G2F Tchem Enzyme -0.17609 1.39 2
Calcium-dependent phospholipase A2 PLA2G5 Tchem Enzyme -1.38065 26.2 137
Cytosolic phospholipase A2 PLA2G4A Tchem Enzyme -2.68316 506.7 274
Peroxisomal acyl-coenzyme A oxidase 1 ACOX1 Tbio Enzyme -2.10178 116.1 292
Cytosolic phospholipase A2 epsilon PLA2G4E Tdark Enzyme -0.25773 2.16 47